Bildkälla: Stockfoto

Annexin: Last patient in and additional readout confirms signal of effect - Redeye

Redeye endorses the latest progress with the ANXV phase II study in RVO and give our initial comment.

Redeye endorses the latest progress with the ANXV phase II study in RVO and give our initial comment.
Börsvärldens nyhetsbrev
ANNONSER